Results 121 to 130 of about 8,387 (243)
The subject of study. AC-mode of chemotherapy-induced cardiotoxicity, and rationality of trimetazidine prescription. Purpose of the study – research the nuclear apparatus state of rats cardiomyocytes on chronic in vivo model of cancer therapy-driven ...
Ашот Арманович Авагимян
doaj
Flow Injection Analysis With Trimetazidine Dihydrochloride Ion-Selective Electrode
New Plastic membrane ion-selective electrode for trimetazidine dihydrochloride based on trimetazidinium-tetraphenylborate was prepared. The electrode exhibited mean calibration graph slope of 29.5 mV per decade of (TrimCl2) concentration at 25°C.
Nour Abdel-Ghani +2 more
core +1 more source
Trimetazidine Increases [\u3csup\u3e3\u3c/sup\u3eH]glucose Uptake in Rat Brain
Trimetazidine, a clinically effective antianginal agent with no negative inotropic or vascular properties, acts by optimizing cardiac energy metabolism through inhibition of free faty acid oxidation, shifting substrate utilization from fatty acids to ...
Gorzałek, Jarosław +8 more
core +1 more source
Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
Trimetazidine is proved to be a highly effective metabolic agent, compared to other drugs with the same action. Trimetazidine shifts cardiac energy metabolism from fatty acid oxidation towards glucose oxidation by inhibiting mitochondrial long-chain 3 ...
A. Yu. Gasparyan +2 more
doaj
ROLE OF TRIMETAZIDINE, A CYTOPROTECTIVE AGENT IN ISCHEMIC HEART DISEASE [PDF]
Objectives: Metabolic agents such as trimetazidine offer a benefits role of cytoprotection in ischemic heart disease (IHD) through an inhibition ofcardiac fatty acid oxidation and improving myocardial glucose utilization.
Manzoor, Sami +4 more
core +1 more source
Prevention of peritoneal adhesions in rats with trimetazidine
The effect of trimetazidine (an antianginal drug that acts as a scavenger of oxygen radicals) in the prevention of peritoneal adhesions induced by complete vascular obstruction of an ileal segment for 30 minutes followed by reperfusion was investigated ...
Page, P. +5 more
core
TRIMETAZIDINE AND MILDRONATE AS DIRECT ACTION Β2 - ADRENOSENSIBILIZERS (EXPERIMENTAL EVIDENCE)
Trimetazidine and mildronate as direct action β2 - adrenosensibilizers (experimental evidence)
T. V. Bratchikova +6 more
core
Does trimetazidine prevent myocardial injury after percutaneous coronary intervention?
Trimetazidine has been known for years as being an effective, ‘‘patient-friendly’’, anti-anginal agent. Recent studies using the modified release formulation (Vastarel MR) have confirmed the efficacy of trimetazidine in stable ischemic heart disease ...
Mario Marzilli, MARZILLI, MARIO
core +1 more source
Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova +4 more
doaj
Cliniko-experimental research of trimetazidine efficiency at the myocardium ischemia
The randomized controllable clinical research of Trimetazidine (Preductal MB) efficiency was spent at 95 patients with a stable angina pectoris. There were revealed the authentic increase in 2 times of treatment’s clinical efficiency in patients, who in ...
O. V Romashchenko
doaj

